4/1
08:09 am
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/6
12:35 pm
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
2/7
08:14 am
itrm
Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
Report
Iterum Therapeutics plc (NASDAQ: ITRM) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.